1
项与 促红素α生物类似药(Megalabs) 相关的临床试验Phase III, Multicentre, Double-blind, Randomised, Parallel, Equivalence Clinical Trial to Assess Efficacy, Safety of Megalabs® Recombinant i/v Human Erythropoietin Compared to Eprex® in Anaemia in Patients With Chronic Kidney Disease
Phase III, multicentre, double-blind, randomised, parallel, equivalence clinical trial to determine the efficacy, safety and immunogenicity of Megalabs® recombinant human alfa epoetin for subcutaneous use, compared to Eprex® (Janssen-Cilag Farmacêutica Ltda.), in the treatment of anaemia in participants with chronic renal disease, dependent on haemodialysis
100 项与 促红素α生物类似药(Megalabs) 相关的临床结果
100 项与 促红素α生物类似药(Megalabs) 相关的转化医学
100 项与 促红素α生物类似药(Megalabs) 相关的专利(医药)
100 项与 促红素α生物类似药(Megalabs) 相关的药物交易